Lista de obras -

A same day 'test and treat' model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt

scientific article published on 30 January 2020

Accumulation of Intrahepatic TNF-α-Producing NKp44+ NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV Infection

artículo científico publicado en 2016

Acute pulmonary embolism

scientific article published on 01 November 2004

Adherence to pan-genotypic glecaprevir/pibrentasvir and efficacy in HCV-infected patients: A pooled analysis of clinical trials

artículo científico publicado en 2019

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

artículo científico publicado en 2011

Changes in autophagic response in patients with chronic hepatitis C virus infection

artículo científico publicado en 2011

Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.

artículo científico publicado en 2006

Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection

scientific article published on 04 August 2019

Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.

artículo científico publicado en 2011

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

article

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients With HCV Genotype 5/6: An Integrated Analysis of Phase 2/3 Studies

artículo científico publicado en 2020

Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study

scientific article published on 25 November 2019

Efficacy of Elbasvir and Grazoprevir in Participants with Hepatitis C Virus Genotype 4 Infection: A Pooled Analysis

artículo científico publicado en 2018

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

artículo científico publicado en 2008

Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study

artículo científico publicado en 2007

Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial.

artículo científico publicado en 2013

Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype 1 HCV: SILEN-C1 trial.

artículo científico publicado en 2013

Future treatments for hepatitis delta virus infection

scientific article published on 01 February 2020

Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.

artículo científico publicado en 2007

High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study

artículo científico publicado en 2009

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.

artículo científico publicado en 2011

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis

artículo científico publicado en 2010

Improving performance of liver biopsy in fibrosis assessment

In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C.

artículo científico publicado en 2010

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

artículo científico publicado en 2007

Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.

artículo científico publicado en 2013

Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C

article

Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT.

artículo científico publicado en 2010

Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy

artículo científico publicado en 2006

MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C.

artículo científico publicado en 2016

Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.

artículo científico publicado en 2005

Patients with chronic hepatitis C without advanced fibrosis and hepatocellular carcinoma: a retrospective clinical-pathological study

artículo científico publicado en 2014

Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for eight weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis

artículo científico publicado en 2020

Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.

artículo científico publicado en 2015

Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C

artículo científico publicado en 2014

Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy

artículo científico publicado en 2011

SCG10 expression on activation of hepatic stellate cells promotes cell motility through interference with microtubules

artículo científico publicado en 2010

Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin

artículo científico publicado en 2006

Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue

artículo científico publicado en 2008

Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.

artículo científico publicado en 2017

Sofosbuvir/Velpatasvir in Patients With Hepatitis C Virus Genotypes 1-6 and Compensated Cirrhosis or Advanced Fibrosis.

artículo científico publicado en 2017

Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin

artículo científico publicado en 2009

Lista de obras de

A same day 'test and treat' model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt

Accumulation of Intrahepatic TNF-α-Producing NKp44+ NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV Infection

Acute pulmonary embolism

Adherence to pan-genotypic glecaprevir/pibrentasvir and efficacy in HCV-infected patients: A pooled analysis of clinical trials

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

Changes in autophagic response in patients with chronic hepatitis C virus infection

Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.

Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection

Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients With HCV Genotype 5/6: An Integrated Analysis of Phase 2/3 Studies

Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study

Efficacy of Elbasvir and Grazoprevir in Participants with Hepatitis C Virus Genotype 4 Infection: A Pooled Analysis

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study

Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial.

Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype 1 HCV: SILEN-C1 trial.

Future treatments for hepatitis delta virus infection

Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.

High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis

Improving performance of liver biopsy in fibrosis assessment

In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C.

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.

Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C

Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT.

Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy

MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C.

Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.

Patients with chronic hepatitis C without advanced fibrosis and hepatocellular carcinoma: a retrospective clinical-pathological study

Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for eight weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis

Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.

Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C

Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy

SCG10 expression on activation of hepatic stellate cells promotes cell motility through interference with microtubules

Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin

Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue

Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.

Sofosbuvir/Velpatasvir in Patients With Hepatitis C Virus Genotypes 1-6 and Compensated Cirrhosis or Advanced Fibrosis.

Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin